Terbinafine Hydrochloride Tablet
Product Images NDC 51991-526

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 51991-526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Terbinafine 01)

Chemical structure of Terbinafine Hydrochloride, illustrating its molecular bonds and atom arrangements including the hydrochloride (HCl) component.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Label for Terbinafine Hydrochloride Tablets, USP 250 mg, oral tablets in a package of 30. The label includes dosage strength, NDC 51991-526-33, storage instructions, distributor Breckenridge Pharmaceutical, Inc., and manufacturer Liconsa in Spain. The label advises pharmacists to dispense a Medication Guide with the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.